4 research outputs found
Universal Coating from Electrostatic Self-Assembly to Prevent Multidrug-Resistant Bacterial Colonization on Medical Devices and Solid Surfaces
We provide a facile
and scalable strategy for preparing gold nanoparticles
(AuNPs)-based antibacterial coating on a variety of surfaces through
electrostatic self-assembly. AuNPs conjugated with 4,6-diamino-2-pyrimidinethiol
(DAPT, not antibacterial by itself), AuDAPT, can form stable coating
on different substrates made from polyethylene (PS), polyvinyl chloride
(PVC), polypropylene (PP), polyethylene (PE), polydimethylsiloxane
(PDMS), and SiO<sub>2</sub> in one step. Such a coating can efficiently
eradicate pathogenic Gram-negative bacteria and even multidrug-resistant
(MDR) mutants without causing any side-effect such as cytotoxicity,
hemolysis, coagulation, and inflammation. We show that immobilized
AuDAPT, instead of AuDAPT released from the substrate, is responsible
for killing the bacteria and that the antimicrobial components do
not enter into the environment to cause secondary contamination to
breed drug resistance. Advantages for such coating include applicability
on a broad range of surfaces, low cost, stability, high antibacterial
efficiency, good biocompatibility, and low risk in antibiotics pollution;
these advantages may be particularly helpful in preventing infections
that involve medical devices
Additional file 1 of Dual peptides-modified cationic liposomes for enhanced Lung cancer gene therapy by a gap junction regulating strategy
Supplementary Material 1: Additional file1. Additional figures and table
Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement
<p><b>Background</b>: The hygroscopicity of raffinose carrier for dry powder inhaler (DPI) was the main obstacle for its further application. Hygroscopicity-induced agglomeration would cause deterioration of aerosolization performance of raffinose, undermining the delivery efficiency.</p> <p><b>Methods</b>: Cyclodextrin-raffinose binary carriers (CRBCs) were produced by spray-drying so as to surmount the above issue. Physicochemical attributes and formation mechanism of CRBCs were explored in detail. The flow property of CRBCs was examined by FT4 Powder Rheometer. Hygroscopicity of CRBCs was elucidated by dynamic vapor sorption study. Aerosolization performance was evaluated by <i>in vitro</i> deposition profile and <i>in vivo</i> pharmacokinetic profile of CRBC based DPI formulations.</p> <p><b>Results</b>: The optimal formulation of CRBC (R<sub>4</sub>) was proven to possess anti-hygroscopicity and aerosolization performance enhancement properties. Concisely, the moisture uptake of R<sub>4</sub> was c.a. 5% which was far lower than spray-dried raffinose (R<sub>0</sub>, c.a. 65%). R<sub>4</sub> exhibited a high fine particle fraction value of 70.56 ± 0.61% and it was 3.75-fold against R<sub>0</sub>. The pulmonary and plasmatic bioavailability of R<sub>4</sub> were significantly higher than R<sub>0</sub> (<i>p</i> < 0.05).</p> <p><b>Conclusion</b>: CRBC with anti-hygroscopicity and aerosolization performance enhancement properties was a promising approach for pulmonary drug delivery, which could provide new possibilities to the application of hygroscopic carriers for DPI.</p